Cardiovascular and metabolic risk factors in patients with subclinical Cushing
ConclusionsSH is linked to relevant cardiovascular and metabolic alterations, leading to worsen clinical outcomes. In eligible patients, adrenalectomy is valid and safe option to treat SH, reducing cardiometabolic abnormalities.
Source: Endocrine - Category: Endocrinology Source Type: research
More News: Cardiology | Cardiovascular | Coronary Artery Bypass Graft | Dexamethasone | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Heart | Heart Attack | Hypertension | Metabolic Syndrome | Obesity | Stroke